Examination of various cohort databases indicated that low UBASH3B expression correlates with poor overall survival in LUAD patients (Fig. S5E and 5F), suggesting a potential tumor-suppressive role for UBASH3B in LUAD. Here, UBASH3B is linked to neoplasm.